Scholarlink

Background <p>Tranexamic acid (TXA) is widely used to reduce perioperative bleeding and transfusion requirements; however, its optimal dosing, efficacy, and safety remain uncertain, particularly in cardiac surgery patients.</p> Methods <p>This single-center, retrospective before-and-after study consecutively included adult patients who underwent cardiac and/or thoracic aortic surgery with cardiopulmonary bypass between 2011 and 2024. Patients were categorized into the before-TXA and after-TXA groups based on the implementation of a routine intraoperative low-dose TXA protocol in December 2017. This protocol included a loading dose (5&#xa0;mg/kg) drawn from a 500&#xa0;mg ampoule and administered at anesthesia induction, with the remaining dose added to the CPB priming volume. A maintenance infusion was administered at 5&#xa0;mg/kg/h throughout surgery. The primary outcome was chest tube output during the first 12&#xa0;h after surgery. Secondary safety outcomes included thrombotic complications and postoperative seizures. Outcomes were compared using interrupted time series analysis after stabilized inverse probability of treatment weighting.</p> Results <p>A total of 4,425 patients were analyzed (2,131 in the before-TXA group and 2,294 in the after-TXA group). The median (interquartile range) chest tube output during the first 12&#xa0;h postoperatively was 480 mL (270–860 mL) in the before-TXA group and 400 mL (230–710 mL) in the after-TXA group. In the interrupted time series analysis, the intercept of log-transformed monthly chest tube output significantly decreased after TXA implementation (<i>β</i><sub><i>2</i></sub> = -0.285; 95% confidence interval, -0.392 to -0.178). There was no significant increase in thrombotic complications or postoperative seizures following intraoperative TXA implementation.</p> Conclusions <p>The routine implementation of low-dose intraoperative TXA in cardiac surgery was associated with a significant reduction in bleeding after cardiac surgery, without an increased risk of thrombotic complications or seizures.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Effectiveness and safety of low-dose intraoperative tranexamic acid in cardiac surgery: a retrospective before-and-after study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月7日

查看全文
  • Jaeyeon Chung,
  • In Jung Kim,
  • Jae-Woo Ju,
  • Chan-ho Hong,
  • Youn Joung Cho,
  • Yunseok Jeon,
  • Karam Nam

摘要

Background

Tranexamic acid (TXA) is widely used to reduce perioperative bleeding and transfusion requirements; however, its optimal dosing, efficacy, and safety remain uncertain, particularly in cardiac surgery patients.

Methods

This single-center, retrospective before-and-after study consecutively included adult patients who underwent cardiac and/or thoracic aortic surgery with cardiopulmonary bypass between 2011 and 2024. Patients were categorized into the before-TXA and after-TXA groups based on the implementation of a routine intraoperative low-dose TXA protocol in December 2017. This protocol included a loading dose (5 mg/kg) drawn from a 500 mg ampoule and administered at anesthesia induction, with the remaining dose added to the CPB priming volume. A maintenance infusion was administered at 5 mg/kg/h throughout surgery. The primary outcome was chest tube output during the first 12 h after surgery. Secondary safety outcomes included thrombotic complications and postoperative seizures. Outcomes were compared using interrupted time series analysis after stabilized inverse probability of treatment weighting.

Results

A total of 4,425 patients were analyzed (2,131 in the before-TXA group and 2,294 in the after-TXA group). The median (interquartile range) chest tube output during the first 12 h postoperatively was 480 mL (270–860 mL) in the before-TXA group and 400 mL (230–710 mL) in the after-TXA group. In the interrupted time series analysis, the intercept of log-transformed monthly chest tube output significantly decreased after TXA implementation (β2 = -0.285; 95% confidence interval, -0.392 to -0.178). There was no significant increase in thrombotic complications or postoperative seizures following intraoperative TXA implementation.

Conclusions

The routine implementation of low-dose intraoperative TXA in cardiac surgery was associated with a significant reduction in bleeding after cardiac surgery, without an increased risk of thrombotic complications or seizures.